Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Raue

Showing results (151-160 of 215) with videos related to

Pageof 22
Sort By:
The American Journal of Medicine|October 1, 1993
Formation of neutralizing antibodies after treatment with human calcitoninA Grauer, H H Reinel, S Lunghall, et al.
Clinical Endocrinology|September 1, 1992
Circulating levels of midregional parathyroid hormone-related protein in hypercalcaemia of malignancyE Blind, F Raue, J Götzmann, et al.
Hormone and Metabolic Research. Supplement Series|January 1, 1989
Diagnostic procedure before reoperation in patients with medullary thyroid carcinomaF Raue, J Winter, K Frank-Raue, et al.
Endocrinology|September 1, 1996
Expression of a calcium-sensing receptor in a human medullary thyroid carcinoma cell line and its contribution to calcitonin secretionM Freichel, A Zink-Lorenz, A Holloschi, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Superior local tolerability of human versus salmon calcitonin preparations in young healthy volunteersC Wüster, W Schurr, S Scharla, et al.
Deutsche Medizinische Wochenschrift (1946)|February 7, 1997
[Mutations of ret-proto-oncogene in thyroid medullary carcinoma]K Frank-Raue, W Höppner, H Buhr, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1996
Application of genetic screening in families with hereditary medullary thyroid carcinomaK Frank-Raue, W Höppner, H Buhr, et al.
Thyroid : Official Journal of the American Thyroid Association|January 1, 1992
Chromogranin A as tumor marker in medullary thyroid carcinomaE Blind, H Schmidt-Gayk, H P Sinn, et al.
Clinical Endocrinology|January 1, 1995
Somatostatin receptor imaging in persistent medullary thyroid carcinomaK Frank-Raue, H Bihl, U Dörr, et al.
Cellular Signalling|January 1, 1992
Inhibition of Ca(2+)-induced calcitonin secretion by somatostatin: roles of voltage dependent Ca2+ channels and G-proteinsH Scherübl, J Hescheler, G Schultz, et al.
Pageof 22

Showing results (151-160 of 215) with videos related to

Sort By:
Pageof 22
The American Journal of Medicine|October 1, 1993
Formation of neutralizing antibodies after treatment with human calcitoninA Grauer, H H Reinel, S Lunghall, et al.
Clinical Endocrinology|September 1, 1992
Circulating levels of midregional parathyroid hormone-related protein in hypercalcaemia of malignancyE Blind, F Raue, J Götzmann, et al.
Hormone and Metabolic Research. Supplement Series|January 1, 1989
Diagnostic procedure before reoperation in patients with medullary thyroid carcinomaF Raue, J Winter, K Frank-Raue, et al.
Endocrinology|September 1, 1996
Expression of a calcium-sensing receptor in a human medullary thyroid carcinoma cell line and its contribution to calcitonin secretionM Freichel, A Zink-Lorenz, A Holloschi, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Superior local tolerability of human versus salmon calcitonin preparations in young healthy volunteersC Wüster, W Schurr, S Scharla, et al.
Deutsche Medizinische Wochenschrift (1946)|February 7, 1997
[Mutations of ret-proto-oncogene in thyroid medullary carcinoma]K Frank-Raue, W Höppner, H Buhr, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1996
Application of genetic screening in families with hereditary medullary thyroid carcinomaK Frank-Raue, W Höppner, H Buhr, et al.
Thyroid : Official Journal of the American Thyroid Association|January 1, 1992
Chromogranin A as tumor marker in medullary thyroid carcinomaE Blind, H Schmidt-Gayk, H P Sinn, et al.
Clinical Endocrinology|January 1, 1995
Somatostatin receptor imaging in persistent medullary thyroid carcinomaK Frank-Raue, H Bihl, U Dörr, et al.
Cellular Signalling|January 1, 1992
Inhibition of Ca(2+)-induced calcitonin secretion by somatostatin: roles of voltage dependent Ca2+ channels and G-proteinsH Scherübl, J Hescheler, G Schultz, et al.
Pageof 22